Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum EastWest Bioscience Inc V.EAST.H

EastWest Bioscience Inc. is a Canada-based vertically integrated wellness company with a multitude of business units and assets that allow for seed-to-sale supply chain management. The Company sources its raw materials, processes, manufactures, tests, brands, markets, and distributes its products to its customers in Canada, the United States and others. It owns and operates retail and... see more

TSXV:EAST.H - Post Discussion

View:
Post by Inoutorstay1 on Apr 24, 2019 12:03pm

No Action

Same old chart everyday . Is patients really a game play here? Or r we fishing in the empty river.
Comment by Goldy63 on Apr 24, 2019 2:28pm
Yah if yoor a crumblord looking to flip I suggest you move on as the play takes time to develope . Next Q,S with sales in Kentucky will show up well and any other news as a surprise is a bonus . If your long you wait . Period . JMO.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities